Thanks for the post. I assume that's the latest news. As such I would expect an up day for SNY Monday. However, wasn't the researcher who set this all off doing a study in the US at UT? Nothing about that was mentioned. Perhaps I just jumped to an errant conclusion.
Surely if the patient groups receiving alternate insulins had different risk factors all this ipso facto statistical reduction is very questionable. One has to remember governments and insurance companies are always looking for justifications to cut drug costs and they have many times in the past come to false conclusions based on such statistical reasoning.